RASAL1 and cancer: Transcriptional suppression of RASAL1 through aberrant promoter methylation contributes to endothelial to mesenchymal transition which was an important source of cancer-associated fibroblasts (CAFs), which are known to facilitate tumor progression in several ways [24].